Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares rose 7% to $7.49 in Friday’s trading session, after the drug maker presented additional 48-week results from its global Phase …
Cantor analyst Elemer Piros initiates coverage on shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), with an Overweight rating and $14 price target, sending shares rising 4.5% in …
As brick-and-mortar stores fall to the wayside, approaching beyond 1,200 closures, top analyst Youssef Squali at Cantor spotlights a “big opportunity” waiting in …
Flexion Therapeutics Inc (NASDAQ:FLXN) shares are on the rise today on the back of rumors that Sanofi (NYSE:SNY) is in talks to acquire …
Deeming Snap Inc (NYSE:SNAP) largely “still a start-up,” top analyst Youssef Squali at Cantor believes the Snapchat-parent company still has a lot left …
Novavax, Inc. (NASDAQ:NVAX) shares fell almost 10% in after-market hours on the heels of the firm’s release of fourth-quarter financials and clinical updates.
In a research report published Friday, Cantor analyst Mara Goldstein reiterated an Overweight rating on shares of Array Biopharma Inc (NASDAQ:ARRY) with a …
Though Cognizant Technology Solutions Corp (NASDAQ:CTSH) underwhelmed slightly on revenue and 2017 guidance when it released fourth-quarter results yesterday, the firm’s quarterly non-GAAP …
With Twitter Inc (NYSE:TWTR) set to deliver fourth-quarter earnings this Thursday, February 9th before market open, top analyst Youssef Squali at Cantor previews …
Cantor top analyst Youssef Squali is modeling for a robust quarter for Facebook Inc (NASDAQ:FB) as he looks ahead to widely anticipated fourth-quarter …
